“A healthy liver stands on a healthy gut” with the gut and its barriers representing the roots
that fuel the liver and expose it to an amazing diverse mixture of gut-derived material/agents …

Background and Aims Cholangiocarcinoma (CCA) is a highly lethal disease without
effective therapeutic approaches. The whole‐genome sequencing data indicate that about …

Faecal microbiota transplantation (FMT) is the transfer of screened and minimally processed
faecal material from a 'healthy'donor to 'diseased'recipient. It has an established role, and is …

Hepatic encephalopathy (HE) is a common and serious neuropsychiatric complication of
cirrhosis, acute liver failure, and porto-systemic shunting. HE largely contributes to the …

La primera guía clínica sobre la encefalopatía hepática se publicó en el año 2009, a casi 14
años de esta primera publicación, numerosos avances en el campo del diagnóstico …

The first clinical guidelines on hepatic encephalopathy were published in 2009. Almost 14
years since that first publication, numerous advances in the field of diagnosis, treatment, and …

Liver disease and gut dysbiosis are strictly associated, and the pathophysiology of this
bidirectional relationship has recently been the subject of several investigations. Growing …

Cholangiocarcinoma (CCA) is a bile duct cancer with a very poor prognosis. Currently, there
is no effective pharmacological treatment available for it. We showed that CCA ubiquitously …

The microbiome of the human gut and liver coexists by influencing the health and disease
state of each system. Fecal microbiota transplantation (FMT) has recently emerged as a …

The formation of liver cirrhosis (LC) is an unfavorable event in the natural history of chronic
liver diseases and with the development of portal hypertension and/or impaired liver function …